Clinical Trial Update: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas [Phase 1, Phase 2]

View source ↗

Summary

This document provides a trial update for RN1701 Injection in Relapsed/refractory B-cell lymphoma, indicating Phase 1 and Phase 2 studies are planned but not ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• RN1701 Injection

Snippet

Sponsor: Affiliated Hospital of Nantong University | Conditions: Relapsed/Refractory B-cell Lymphoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING